Grant: Travel Awards - Institute Community Support
University of Alberta
$3,000.00
Using synthetic virology approaches to elucidate novel virus-host interactions and develop targeted therapeutics
EF 2023-24
Résumé
The central theme of my research program will study poxvirus-host cellular interactions to develop effective and more personalized biotherapeutics (vaccines and oncolytic viruses [OVs]) towards cancers and infectious diseases using synthetic virology approaches. I am interested in harnessing the power of these technologies to study how cellular antiviral responses are differentially induced in various cell types during poxvirus infections. I am also interested in the relationship between nucleic acid sensing pathways and other poxvirus biological processes (like transcription, replication, and recombination). I plan to extend these studies to investigate the role of known and unknown viral antagonists of nucleic acid sensing on these processes. I will use my skills in rapidly generating recombinant poxviruses using synthetic biology technologies to discover what makes viruses able to replicate efficiently in some cell types, and not others. Understanding why poxviruses preferentially replicate in certain cell types or species will enhance their utility as cancer therapeutics. Results from these basic molecular virology studies will inform my studies on generating more potent OVs, whether alone, or in combination with other treatment modalities, like adoptive cell therapies, radiation, or in combination with OVs from unrelated virus families. I am also interested in whether these modified viruses can be used as vaccines to increase the magnitude and durability of an immune response to emerging/re-emerging viruses, including monkeypox virus and SARS-CoV-2.
Programme
Travel Awards - Institute Community Support
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
495160
Name
Noyce Ryan S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Travel Awards - Institute Community Support
Projecttitle
Using synthetic virology approaches to elucidate novel virus-host interactions and develop targeted therapeutics
Programtype2
Undefined
Orgnameinp2
University of Alberta
Cihramount2
$3,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Antiviral Responses; Ics Travel Awards; Immunotherapy; Oncolytic Virotherapy; Poxviruses; Synthetic Virology; Viral Pathogenesis
Abstract
The central theme of my research program will study poxvirus-host cellular interactions to develop effective and more personalized biotherapeutics (vaccines and oncolytic viruses [OVs]) towards cancers and infectious diseases using synthetic virology approaches. I am interested in harnessing the power of these technologies to study how cellular antiviral responses are differentially induced in various cell types during poxvirus infections. I am also interested in the relationship between nucleic acid sensing pathways and other poxvirus biological processes (like transcription, replication, and recombination). I plan to extend these studies to investigate the role of known and unknown viral antagonists of nucleic acid sensing on these processes. I will use my skills in rapidly generating recombinant poxviruses using synthetic biology technologies to discover what makes viruses able to replicate efficiently in some cell types, and not others. Understanding why poxviruses preferentially replicate in certain cell types or species will enhance their utility as cancer therapeutics. Results from these basic molecular virology studies will inform my studies on generating more potent OVs, whether alone, or in combination with other treatment modalities, like adoptive cell therapies, radiation, or in combination with OVs from unrelated virus families. I am also interested in whether these modified viruses can be used as vaccines to increase the magnitude and durability of an immune response to emerging/re-emerging viruses, including monkeypox virus and SARS-CoV-2.
Competitiondate
202310
Approvedterm2
1 yr 0 mth
Pinamesdelim
Noyce, Ryan S
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $3,000~ $0~